Clinical Trial Update: A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating the safety and preliminary efficacy of a single infusion of stimulated autologous CD4+ T cells in relapsing-remitting multiple scle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Stimulated autologous CD4+ T cells

Snippet

Sponsor: Imcyse SA | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 1, Phase 2 | Status: TERMINATED